SAB Biotherapeutics, Inc. insider trading activity

Understanding Insider Activity at SAB Biotherapeutics, Inc.

Welcome to our dedicated page for SAB Biotherapeutics, Inc. (Nasdaq: SABS) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by SAB Biotherapeutics, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for SAB Biotherapeutics, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for SABS
TickerTime & DateFilingLink
SABS1:00:05 PM, 12/8/2023
Sullivan Eddie Joe(Chief Executive Officer) purchased 1740 shares of SAB Biotherapeutics, Inc. (SABS) for ~$1531
Filing
SABS10:00:07 PM, 11/30/2023
King Michael(CHIEF FINANCIAL OFFICER) purchased 5000 shares of SAB Biotherapeutics, Inc. (SABS) for ~$4500
Filing
SABS1:00:04 PM, 11/30/2023
Reich Samuel J(Executive Chairman) purchased 11000 shares of SAB Biotherapeutics, Inc. (SABS) for ~$9790
Filing